Stockholm, Sweden – Barnik Invest AB, today announced a strategic investment in Bonimedics.com, to build a pioneering e-commerce platform poised to become a market leader in the medical aesthetics and food supplements market. This investment is made within StartUpPharma, a wholly-owned subsidiary of Barnik Invest AB focused on facilitating market access for life science companies.
“We are excited to invest in Bonimedics.com to build a world-class e-commerce destination for medical aesthetics and food supplements” said Hamid Bakhshi, CEO of Barnik Invest AB. “Our investment in Bonimedics.com will enable us to expand our reach and serve a wider customer base with high quality food supplements and medical devices.”
Bonimedics.com will curate a comprehensive selection of the latest and most effective medical devices and food supplements and will provide an exceptional shopping experience, empowering customers to make informed decisions.
For more information, please contact;
Hamid Bakhshi, CEO
Telephone: +46738531165
E-mail: hamid.bakhshi@barnikinvest.com
About Barnik Invest Group
Barnik Invest Group is a leading 360 solution partner for small Life Science companies in the Nordics. The company provides a comprehensive suite of services to support its portfolio companies, including capital, clinical development, expertise, and commercialization. Through its fully-owned subsidiaries, Medicorent and StartUpPharma, Barnik Invest offers CRO services, outsourcing, recruitment, distribution, product development and commercialization solutions. Barnik’s mission is to nurture promising life science companies from early clinical development phase to commercialization, enabling them to achieve positive cash flows or successful exits and ultimately enhancing patient well-being and improving human health worldwide. For more information visit www.barnikinvest.com.
